Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain-Reference-Cited by-同舟云学术

Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain

Published:2013-08-20 Issue:1 Volume:37 Page:29-40
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Magnusson Kristina¹,Sehlin Dag¹,Syvänen Stina¹,Svedberg Marie M.¹²,Philipson Ola¹,Söderberg Linda³,Tegerstedt Karin³,Holmquist Mats³,Gellerfors Pär³,Tolmachev Vladimir⁴,Antoni Gunnar²⁵,Lannfelt Lars¹,Hall Håkan²,Nilsson Lars N.G.¹⁶

Affiliation:

1. Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden

2. Department of Medicinal Chemistry, Preclinical PET Platform, Uppsala University, Uppsala, Sweden

3. BioArctic Neuroscience AB, Stockholm, Sweden

4. Department of Radiology, Oncology and Radiation Science, Biomedical Radiation Sciences, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden

5. PET Centre, Uppsala University Hospital, Uppsala, Sweden

6. Department of Pharmacology, Oslo University and Oslo University Hospital, Oslo, Norway

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on immunotherapy in neurodegenerative diseases;Brain Research;2024-12

2. Disease modifying effects of the amyloid-beta protofibril-selective antibody mAb158 in aged Tg2576 transgenic mice;Molecular and Cellular Neuroscience;2024-09

3. Population pharmacokinetics and exposure–response analyses of safety (ARIA‐E and isolated ARIA‐H) of lecanemab in subjects with early Alzheimer's disease;CPT: Pharmacometrics & Systems Pharmacology;2024-08-29

4. Targeting soluble amyloid-beta oligomers with a novel nanobody;Scientific Reports;2024-07-12

5. Unraveling Alzheimer’s: the promise of aducanumab, lecanemab, and donanemab;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-06-14